Antiproliferative effects of 13α/β-steroids on triple-negative MDA-MB-231 breast cancer cells: unraveling intracellular signaling without ERα. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 59, p. e22540, 2023. DOI: 10.1590/s2175-97902023e22540. Disponível em: https://www.revistas.usp.br/bjps/article/view/211876.. Acesso em: 30 apr. 2024.